Showing results (11-20 of 43) with videos related to
Sort By:
Pageof 5
Plos One|August 17, 2018
Correction: An evaluation of emergency guidelines issued by the World Health Organization in response to four infectious disease outbreaksSusan L Norris, Veronica Ivey Sawin, Mauricio Ferri, et al.Cancer Journal (Sudbury, Mass.)|March 25, 2022
Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining ProgressDonna R Rivera, Paul G Kluetz, Kald Abdallah, et al.Journal of Health Care for the Poor and Underserved|July 19, 2023
Understanding Hispanic/Latino Participation in Clinical Trials and Observational Studies, and Strategies to Increase Participation: A Targeted Literature ReviewBrian Dreyfus, Lorena Kuri, Mauricio Ferri, et al.Thrombosis Research|February 27, 2023
Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancerAmol D Dhamane, Shrushti Shah, Virginia Noxon, et al.Hospital Practice (1995)|July 29, 2020
Clinical characteristics and treatment patterns of patients with venous thromboembolism (VTE) transitioning from hospital to post-discharge settingsTanya Burton, Patrick Hlavacek, Jennifer D Guo, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 15, 2026
Trajectory of Kidney Function in T1D over Time: A Scoping ReviewFavian Co, Reid Whitlock, Arvind Katta, et al.Journal of Evidence-Based Medicine|June 20, 2019
An evaluation of WHO emergency guidelines for Zika virus diseaseSusan L Norris, Henry Louis, Veronica I Sawin, et al.Advances in Therapy|December 17, 2022
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and MultimorbidityAmol D Dhamane, Mauricio Ferri, Allison Keshishian, et al.Journal of Thrombosis and Thrombolysis|August 2, 2023
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillationBrett D Atwater, Jennifer D Guo, Allison Keshishian, et al.Thrombosis Research|December 21, 2020
Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare populationJennifer D Guo, Patrick Hlavacek, Lisa Rosenblatt, et al.Pageof 5